Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Home
Current
Archives
Manuscript Submission
Announcements
Editorial Review Board
Permissions and Licensing
Subscription Information
Advertising Information
Library Referral Form
Library Referral Form - Online
Reprints
The Future of Opioids
Special Issue on Buprenorphine
Special on Legal and Regulatory Aspects of Opioids
Webinars
BUPE2024
User License Agreement
Call for Papers - Updated
About
About the Journal
Editorial Team
Privacy Statement
Contact
Search
Register
Login
Home
/
Archives
/
Vol. 12 No. 2 (2016): March/April
Vol. 12 No. 2 (2016): March/April
Published:
03/01/2016
Letters to the Editor
The prescription opioid epidemic in developed versus underdeveloped countries: Is there a happy medium?
Roland N. Kaddoum, MD, Doralina L. Anghelescu, MD, Cynthia Karam, Marie T. Aouad, MD, Eveline Hitti, MD, MBA
93-95
PDF
Articles
Establishing “abuse-deterrence equivalence” for generic abuse-deterrent opioid formulations: A proposed development framework
Beatrice Setnik, PhD, Edward J. Cone, PhD
96-100
Requires Subscription or Fee
PDF
(USD 56)
The emerging therapeutic roles of κ-opioid agonists
Mark R. Jones, MD, Alan David Kaye, MD, PhD, Aaron J. Kaye, BA, Richard D. Urman, MD, MBA
101-107
Requires Subscription or Fee
PDF
(USD 56)
State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic review
Francesca L. Beaudoin, MD, MS, Geetanjoli N. Banerjee, MPH, Michael J. Mello, MD, MPH
109-118
Requires Subscription or Fee
PDF
(USD 56)
Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center
Steven Schultz, PharmD, Carol Chamberlain, PharmD, Psych MA, Marius Vulcan, MD, Humair Rana, MD, Bhavin Patel, PharmD, MBA, John C. Alexander, MD
119-122
Requires Subscription or Fee
PDF
(USD 56)
Methadone conversion in infants and children: Retrospective cohort study of 199 pediatric inpatients
Alexandra Fife, PharmD, Andrea Postier, MPH, Andrew Flood, PhD, Stefan J. Friedrichsdorf, MD, FAAP
123-130
Requires Subscription or Fee
PDF
(USD 56)
Methadone prolongs cardiac conduction in young patients with cancer-related pain
Doralina L. Anghelescu, MD, Rakesh M. Patel, MD, Daniel P. Mahoney, MD, Luis Trujillo, MD, Lane G. Faughnan, BSN, Brenda D. Steen, MSN, Justin N. Baker, MD, Deqing Pei, MS
131-138
Requires Subscription or Fee
PDF
(USD 56)
Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential
Martin E. Hale, MD, Yuju Ma, MS, Richard Malamut, MD
139-147
Requires Subscription or Fee
PDF
(USD 56)
Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients
Christopher Sankey, MD, CCFP (EM), Beatrice Setnik, PhD, Zoltan Harsanyi, BSc (Hon), MLS, MBA, PStat. (SSC), PSTAT® (ASA), Ken Michalko, PharmD, MBA, Zejiang Yang, PhD, Pierre Geoffroy, MDCM, MSc, FCFP, DABAM
149-159
Requires Subscription or Fee
PDF
(USD 56)
Old JOM header
ad_block_3
Subscription
Login to access subscriber-only resources.
Make a Submission
Make a Submission
Information
For Readers
For Authors
For Librarians
Keywords
Announcements